# Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

> **NCT05237986** · — · RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 60 (estimated)

## Conditions studied

- Lymphoma
- Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05237986
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-23
- **Primary completion:** 2026-04-30
- **Final completion:** 2027-04-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05237986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05237986, "Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT05237986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*